CXCL8 and colorectal cancer: Our recent work identified a p53−/− cell-specific, oxaliplatin treatment-specific upregulation of IL-8 and a p53−/− cell-specific, cisplatin treatment-specific upregulation of ferritin among colorectal cancer cells treated with either 5-FU, irinotecan, oxaliplatin, or cisplatin.